Krystal Biotech Inc (KRYS)
$178.71
Krystal Biotech Inc (KRYS) Share Price Forecast
Currently 17 wall-street analysts regularly analyze the financials of Krystal Biotech Inc on a frequent basis to provide recommendations along with target share price. 17 analysts offering 12-month price forecasts for Krystal Biotech Inc (KRYS) have a share price target of $207.22. This median of share price forecast represents a 15.95% upside from the latest price of $178.71 as on 14.10.24.
Krystal Biotech Inc (KRYS) Price vs Consensus Price Target
Price
Target Price
As per the chart shown above, analysts believe that the Krystal Biotech Inc (KRYS) share price will touch around $207.22 in next 12-months.
Krystal Biotech Inc (KRYS) Share Price Forecast v/s Share Price Today
Below is a chart showing the percentage difference between Krystal Biotech Inc's share price and its median forecast price. As on 14.10.24, the difference is -12.43%
Krystal Biotech Inc (KRYS): Difference between Current Price & Median Forecasted Price
Difference in Percentage terms
Krystal Biotech Inc (KRYS) Share Price : Analyst Recommendation
Based on 17 analysts tracking and researching Krystal Biotech Inc (KRYS) share have buy recommendation on an average.
| 3M Ago | 1M Ago | Current | |
| Buy | 9 | 9 | 9 |
| Outperform | 7 | 7 | 7 |
| Hold | 1 | 1 | 1 |
| Underperform | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 |
Krystal Biotech Inc (KRYS) Share Price Technical Analysis
50 Day Moving Average v/s Current Share Price
Moving Average
Price
200 Day Moving Average v/s Current Share Price
Moving Average
Price
FAQs
The latest share price target for Krystal Biotech Inc (KRYS) is $207.22, offered by 17 analysts offering 12-month price forecasts.
Krystal Biotech Inc (KRYS) has a maximum of 0.16 upside potential, based on 17 analysts offering 12-month price forecasts.
Based on 17 analysts tracking and researching Krystal Biotech Inc (KRYS), 94.12% have a buy recommendation. Remaining 5.88% have either sell or hold recommendations.
The latest share price of Krystal Biotech Inc (KRYS) is $178.71 as of 14/10/2024.
16 of total 17 analysts offering stock ratings for Krystal Biotech Inc KRYS have recommended buy rating.
₹0 US Stocks a/c Opening Fee